{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T05:04:56Z","timestamp":1789275896715,"version":"build-2803163510"},"reference-count":116,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82001113"],"award-info":[{"award-number":["82001113"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["82001113"],"award-info":[{"award-number":["82001113"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a clinically and biologically heterogeneous neurodegenerative disorder in which variable symptom profiles, progression rates, and treatment responses likely reflect distinct but partially convergent pathogenic mechanisms. Among these, mitochondrial dysfunction recurs across both familial and sporadic PD; however, this broad concept alone cannot explain disease heterogeneity. To preserve mitochondrial homeostasis, cells rely on a complex mitochondrial quality control (MQC) system that encompasses protein import and proteostasis, redox surveillance, organellar dynamics and positioning, biogenesis, and selective elimination of damaged mitochondria. MQC also depends on coordination with other organelles, particularly the endoplasmic reticulum and lysosomes. In this review, we discuss how different layers of MQC maintain mitochondrial integrity and how these pathways are functionally coupled. We further consider how an MQC-based framework may help explain the clinical heterogeneity of PD, including selective neuronal vulnerability, subtype formation, and divergent disease progression, and how it can frame recent therapeutic advances aimed at biologically stratified intervention.<\/jats:p>","DOI":"10.3390\/ijms27188086","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T10:51:37Z","timestamp":1789123897000},"page":"8086","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitochondrial Quality Control Imbalance in the Heterogeneity of Parkinson\u2019s Disease: From Selective Vulnerability to Stratified Transformation"],"prefix":"10.3390","volume":"27","author":[{"given":"Yongxu","family":"Chen","sequence":"first","affiliation":[{"name":"College of Life Science, Northeast Forestry University, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4521-3320","authenticated-orcid":false,"given":"Chunsheng","family":"Wang","sequence":"additional","affiliation":[{"name":"College of Life Science, Northeast Forestry University, Harbin 150040, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s Disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s Disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/ana.23687","article-title":"Meta-analysis of Early Nonmotor Features and Risk Factors for Parkinson Disease","volume":"72","author":"Noyce","year":"2012","journal-title":"Ann. Neurol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease","volume":"76","author":"Lees","year":"2019","journal-title":"JAMA Neurol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jia, F., Fellner, A., and Kumar, K.R. (2022). Monogenic Parkinson\u2019s Disease: Genotype, Phenotype, Pathophysiology, and Genetic Testing. Genes, 13.","DOI":"10.3390\/genes13030471"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41588-023-01584-8","article-title":"Multi-Ancestry Genome-Wide Association Meta-Analysis of Parkinson\u2019s Disease","volume":"56","author":"Kim","year":"2024","journal-title":"Nat. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","article-title":"Inflammation and Immune Dysfunction in Parkinson Disease","volume":"22","author":"Tansey","year":"2022","journal-title":"Nat. Rev. Immunol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1038\/emboj.2012.170","article-title":"Mitochondrial Dysfunction in Parkinson\u2019s Disease: Molecular Mechanisms and Pathophysiological Consequences","volume":"31","author":"Exner","year":"2012","journal-title":"EMBO J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41531-023-00564-3","article-title":"Parkinson\u2019s Disease Neurons Exhibit Alterations in Mitochondrial Quality Control Proteins","volume":"9","author":"Chen","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13024-020-00367-7","article-title":"PINK1 and Parkin Mitochondrial Quality Control: A Source of Regional Vulnerability in Parkinson\u2019s Disease","volume":"15","author":"Ge","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Hu, D., Liu, Z., and Qi, X. (2021). Mitochondrial Quality Control Strategies: Potential Therapeutic Targets for Neurodegenerative Diseases?. Front. Neurosci., 15.","DOI":"10.3389\/fnins.2021.746873"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1152\/physrev.00041.2021","article-title":"Mitochondrial Quality Control in Health and in Parkinson\u2019s Disease","volume":"102","author":"Eldeeb","year":"2022","journal-title":"Physiol. Rev."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"R170","DOI":"10.1016\/j.cub.2018.01.004","article-title":"Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance","volume":"28","author":"Pickles","year":"2018","journal-title":"Curr. Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1007\/s00018-021-03775-0","article-title":"Mitochondrial Quality Control: From Molecule to Organelle","volume":"78","author":"Tait","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/ars.2014.6199","article-title":"Mitochondrial Protein Quality Control: The Mechanisms Guarding Mitochondrial Health","volume":"22","author":"Bohovych","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nature12985","article-title":"Mitochondrial Form and Function","volume":"505","author":"Friedman","year":"2014","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.emboj.7601963","article-title":"Fission and Selective Fusion Govern Mitochondrial Segregation and Elimination by Autophagy","volume":"27","author":"Twig","year":"2008","journal-title":"EMBO J."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1126\/science.1219855","article-title":"Mitochondrial Fission, Fusion, and Stress","volume":"337","author":"Youle","year":"2012","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"102747","DOI":"10.1016\/j.conb.2023.102747","article-title":"Mitochondrial Regulation of Local Supply of Energy in Neurons","volume":"81","author":"Kittler","year":"2023","journal-title":"Curr. Opin. Neurobiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1083\/jcb.201312123","article-title":"Mitochondrial Trafficking and Anchoring in Neurons: New Insight and Implications","volume":"204","author":"Sheng","year":"2014","journal-title":"J. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Narendra, D.P., Jin, S.M., Tanaka, A., Suen, D.-F., Gautier, C.A., Shen, J., Cookson, M.R., and Youle, R.J. (2010). PINK1 Is Selectively Stabilized on Impaired Mitochondria to Activate Parkin. PLoS Biol., 8.","DOI":"10.1371\/journal.pbio.1000298"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1242\/jcs.093849","article-title":"PINK1- and Parkin-Mediated Mitophagy at a Glance","volume":"125","author":"Jin","year":"2012","journal-title":"J. Cell Sci."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1038\/ncomms3428","article-title":"Bit-by-Bit Autophagic Removal of Parkin-Labelled Mitochondria","volume":"4","author":"Yang","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"R\u00fchmkorf, A., and Harbauer, A.B. (2023). Role of Mitochondria\u2013ER Contact Sites in Mitophagy. Biomolecules, 13.","DOI":"10.3390\/biom13081198"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nature13392","article-title":"Ubiquitin Is Phosphorylated by PINK1 to Activate Parkin","volume":"510","author":"Koyano","year":"2014","journal-title":"Nature"},{"key":"ref_26","first-page":"32","article-title":"Mitochondrial Quality Control in Human Health and Disease","volume":"11","author":"Liu","year":"2024","journal-title":"Mil. Med. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-biochem-060815-014352","article-title":"Mitochondrial Machineries for Protein Import and Assembly","volume":"86","author":"Wiedemann","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"ref_28","first-page":"342ra78","article-title":"\u03b1-Synuclein Binds to TOM20 and Inhibits Mitochondrial Protein Import in Parkinson\u2019s Disease","volume":"8","author":"Barrett","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"13548","DOI":"10.1038\/ncomms13548","article-title":"Defective Mitochondrial DNA Homeostasis in the Substantia Nigra in Parkinson Disease","volume":"7","author":"Nido","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"52ra73","DOI":"10.1126\/scitranslmed.3001059","article-title":"PGC-1 \u03b1, A Potential Therapeutic Target for Early Intervention in Parkinson\u2019s Disease","volume":"2","author":"Zheng","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","article-title":"Elevated Mitochondrial Bioenergetics and Axonal Arborization Size Are Key Contributors to the Vulnerability of Dopamine Neurons","volume":"25","author":"Pacelli","year":"2015","journal-title":"Curr. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective Neuronal Vulnerability in Parkinson Disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41467-021-22113-3","article-title":"Dysregulation of Mitochondria-Lysosome Contacts by GBA1 Dysfunction in Dopaminergic Neuronal Models of Parkinson\u2019s Disease","volume":"12","author":"Kim","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson Disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s Disease: From Mechanism to Therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.aam9080","article-title":"Dopamine Oxidation Mediates Mitochondrial and Lysosomal Dysfunction in Parkinson\u2019s Disease","volume":"357","author":"Burbulla","year":"2017","journal-title":"Science"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/s41593-022-01061-1","article-title":"Single-Cell Genomic Profiling of Human Dopamine Neurons Identifies a Population That Selectively Degenerates in Parkinson\u2019s Disease","volume":"25","author":"Kamath","year":"2022","journal-title":"Nat. Neurosci."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/brain\/122.8.1437","article-title":"The substantia nigra of the human brain II. Patterns of loss of dopamine-containing neurons in Parkinson\u2019s disease","volume":"122","author":"Damier","year":"1999","journal-title":"Brain"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/s41386-018-0151-4","article-title":"Ventral Midbrain Astrocytes Display Unique Physiological Features and Sensitivity to Dopamine D2 Receptor Signaling","volume":"44","author":"Xin","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1002\/glia.23627","article-title":"Subregional Differences in Astrocytes Underlie Selective Neurodegeneration or Protection in Parkinson\u2019s Disease Models in Culture","volume":"67","author":"Kostuk","year":"2019","journal-title":"Glia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nature18928","article-title":"Transfer of Mitochondria from Astrocytes to Neurons after Stroke","volume":"535","author":"Hayakawa","year":"2016","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.1073\/pnas.1404651111","article-title":"Transcellular Degradation of Axonal Mitochondria","volume":"111","author":"Davis","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41531-018-0044-6","article-title":"Mitochondrial Dysfunction within the Synapses of Substantia Nigra Neurons in Parkinson\u2019s Disease","volume":"4","author":"Reeve","year":"2018","journal-title":"npj Park. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.neuron.2014.12.007","article-title":"The Roles of PINK1, Parkin, and Mitochondrial Fidelity in Parkinson\u2019s Disease","volume":"85","author":"Pickrell","year":"2015","journal-title":"Neuron"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Tang, T., Jian, B., and Liu, Z. (2023). Transmembrane Protein 175, a Lysosomal Ion Channel Related to Parkinson\u2019s Disease. Biomolecules, 13.","DOI":"10.3390\/biom13050802"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41531-024-00735-w","article-title":"Neurovascular and Immune Factors of Vulnerability of Substantia Nigra Dopaminergic Neurons in Non-Human Primates","volume":"10","author":"Balzano","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.25135","article-title":"Living on the Edge with Too Many Mouths to Feed: Why Dopamine Neurons Die","volume":"27","author":"Bolam","year":"2012","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/s41586-021-04059-0","article-title":"Disruption of Mitochondrial Complex I Induces Progressive Parkinsonism","volume":"599","author":"Zampese","year":"2021","journal-title":"Nature"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Franco-Iborra, S., Vila, M., and Perier, C. (2018). Mitochondrial Quality Control in Neurodegenerative Diseases: Focus on Parkinson\u2019s Disease and Huntington\u2019s Disease. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00342"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e202105043","DOI":"10.1083\/jcb.202105043","article-title":"Mitochondrial Regulation of Ferroptosis","volume":"220","author":"Gan","year":"2021","journal-title":"J. Cell Biol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"15365","DOI":"10.1038\/s41598-023-42574-4","article-title":"Ferroptosis-Related Factors in the Substantia Nigra Are Associated with Parkinson\u2019s Disease","volume":"13","author":"Liu","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","article-title":"Synaptic, Mitochondrial, and Lysosomal Dysfunction in Parkinson\u2019s Disease","volume":"42","author":"Nguyen","year":"2019","journal-title":"Trends Neurosci."},{"key":"ref_53","first-page":"13","article-title":"PINK1, Parkin, and Mitochondrial Quality Control: What Can We Learn about Parkinson\u2019s Disease Pathobiology?","volume":"7","author":"Truban","year":"2016","journal-title":"J. Park. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-024-00677-3","article-title":"Genotype\u2013Phenotype Correlation in PRKN-Associated Parkinson\u2019s Disease","volume":"10","author":"Menon","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41531-021-00273-9","article-title":"Lewy Body Disease or Diseases with Lewy Bodies?","volume":"8","author":"Colosimo","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.1073\/pnas.0913485107","article-title":"Drosophila Parkin Requires PINK1 for Mitochondrial Translocation and Ubiquitinates Mitofusin","volume":"107","author":"Ziviani","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/nm.3232","article-title":"The Role of Autophagy in Neurodegenerative Disease","volume":"19","author":"Nixon","year":"2013","journal-title":"Nat. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson\u2019s Disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","article-title":"Gaucher Disease Glucocerebrosidase and \u03b1-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies","volume":"146","author":"Mazzulli","year":"2011","journal-title":"Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"eabb2454","DOI":"10.1126\/sciadv.abb2454","article-title":"LRRK2 Mediates Tubulation and Vesicle Sorting from Lysosomes","volume":"6","author":"Beilina","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1093\/hmg\/ddu138","article-title":"Membrane Recruitment of Endogenous LRRK2 Precedes Its Potent Regulation of Autophagy","volume":"23","author":"Schapansky","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41531-022-00354-3","article-title":"LRRK2 Kinase Activity Regulates GCase Level and Enzymatic Activity Differently Depending on Cell Type in Parkinson\u2019s Disease","volume":"8","author":"Kedariti","year":"2022","journal-title":"npj Park. Dis."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/ng1884","article-title":"Hereditary Parkinsonism with Dementia Is Caused by Mutations in ATP13A2, Encoding a Lysosomal Type 5 P-Type ATPase","volume":"38","author":"Ramirez","year":"2006","journal-title":"Nat. Genet."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1073\/pnas.1616332114","article-title":"TMEM175 Deficiency Impairs Lysosomal and Mitochondrial Function and Increases \u03b1-Synuclein Aggregation","volume":"114","author":"Jinn","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nature23269","article-title":"The Lysosomal Potassium Channel TMEM175 Adopts a Novel Tetrameric Architecture","volume":"547","author":"Lee","year":"2017","journal-title":"Nature"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00702-024-02774-2","article-title":"Current Trends in Basic Research on Parkinson\u2019s Disease: From Mitochondria, Lysosome to \u03b1-Synuclein","volume":"131","author":"Matsui","year":"2024","journal-title":"J. Neural Transm."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrneurol.2010.145","article-title":"Cell-to-Cell Transmission of Non-Prion Protein Aggregates","volume":"6","author":"Lee","year":"2010","journal-title":"Nat. Rev. Neurol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nature14547","article-title":"\u03b1-Synuclein Strains Cause Distinct Synucleinopathies after Local and Systemic Administration","volume":"522","author":"Peelaerts","year":"2015","journal-title":"Nature"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1038\/ncomms3575","article-title":"Structural and Functional Characterization of Two Alpha-Synuclein Strains","volume":"4","author":"Bousset","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Vicario, M., Cieri, D., Brini, M., and Cal\u00ec, T. (2018). The Close Encounter Between Alpha-Synuclein and Mitochondria. Front. Neurosci., 12.","DOI":"10.3389\/fnins.2018.00388"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1038\/emboj.2010.223","article-title":"Inhibition of Mitochondrial Fusion by A-synuclein Is Rescued by PINK1, Parkin and DJ-1","volume":"29","author":"Kamp","year":"2010","journal-title":"EMBO J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/mds.26562","article-title":"Lysosomal Dysfunction and \u03b1-Synuclein Aggregation in Parkinson\u2019s Disease: Diagnostic Links","volume":"31","author":"Moors","year":"2016","journal-title":"Mov. Disord."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrn3961","article-title":"Compromised Autophagy and Neurodegenerative Diseases","volume":"16","author":"Menzies","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.201003122","article-title":"\u03b1-Synuclein Impairs Macroautophagy: Implications for Parkinson\u2019s Disease","volume":"190","author":"Winslow","year":"2010","journal-title":"J. Cell Biol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/cr.2018.16","article-title":"UPRmt Regulation and Output: A Stress Response Mediated by Mitochondrial-Nuclear Communication","volume":"28","author":"Melber","year":"2018","journal-title":"Cell Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nature18302","article-title":"Mitochondrial Unfolded Protein Response Controls Matrix Pre-RNA Processing and Translation","volume":"534","author":"Harper","year":"2016","journal-title":"Nature"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40035-015-0042-0","article-title":"Neuroinflammation in Parkinson\u2019s Disease and Its Potential as Therapeutic Target","volume":"4","author":"Wang","year":"2015","journal-title":"Transl. Neurodegener."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e08503","DOI":"10.1002\/advs.202408503","article-title":"NAD+-Boosters Improve Mitochondria Quality Control In Parkinson\u2019s Disease Models Via Mitochondrial UPR","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eaat8657","DOI":"10.1126\/science.aat8657","article-title":"cGAS in Action: Expanding Roles in Immunity and Inflammation","volume":"363","author":"Ablasser","year":"2019","journal-title":"Science"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1038\/s41401-022-00879-6","article-title":"Mitochondrial-Derived Damage-Associated Molecular Patterns Amplify Neuroinflammation in Neurodegenerative Diseases","volume":"43","author":"Lin","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/cns.14157","article-title":"Microglial cGAS Drives Neuroinflammation in the MPTP Mouse Models of Parkinson\u2019s Disease","volume":"29","author":"Ma","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(19)30287-X","article-title":"The Genetic Architecture of Parkinson\u2019s Disease","volume":"19","author":"Blauwendraat","year":"2020","journal-title":"Lancet Neurol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tibs.2015.02.003","article-title":"Mitochondrial Dysfunction and Mitophagy in Parkinson\u2019s: From Familial to Sporadic Disease","volume":"40","author":"Ryan","year":"2015","journal-title":"Trends Biochem. Sci."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/nm.4001","article-title":"Proteostasis and Aging","volume":"21","author":"Kaushik","year":"2015","journal-title":"Nat. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol."},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Erro, R., Vitale, C., Amboni, M., Picillo, M., Moccia, M., Longo, K., Santangelo, G., De Rosa, A., Allocca, R., and Giordano, F. (2013). The Heterogeneity of Early Parkinson\u2019s Disease: A Cluster Analysis on Newly Diagnosed Untreated Patients. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0070244"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of Brain Pathology Related to Sporadic Parkinson\u2019s Disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-Motor Features of Parkinson Disease","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS Clinical Diagnostic Criteria for Parkinson\u2019s Disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.molcel.2016.01.028","article-title":"The Mitochondrial Basis of Aging","volume":"61","author":"Sun","year":"2016","journal-title":"Mol. Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1126\/science.1201940","article-title":"Mitochondria and the Autophagy\u2013Inflammation\u2013Cell Death Axis in Organismal Aging","volume":"333","author":"Green","year":"2011","journal-title":"Science"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/s41467-024-49949-9","article-title":"Neuroimaging and Fluid Biomarkers in Parkinson\u2019s Disease in an Era of Targeted Interventions","volume":"15","author":"Zarkali","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","article-title":"A Biological Classification of Parkinson\u2019s Disease: The SynNeurGe Research Diagnostic Criteria","volume":"23","author":"Adler","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_95","unstructured":"Fiesel, F.C., Watzlawik, J.O., Heckman, M.G., Blumenfeld, S.G., Rigby, M.J., Kehili, M., Lohmann, K., Klein, C., Narendra, D.P., and Scherzer, C.R. (2025). Phosphorylated Ubiquitin as a Clinical Biomarker for Mitochondrial Damage in Neurodegenerative Diseases. Aging Dis., Online ahead of print."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mds.29297","article-title":"LRRK2 Inhibition by BIIB122 in Healthy Participants and Patients with Parkinson\u2019s Disease","volume":"38","author":"Jennings","year":"2023","journal-title":"Mov. Disord."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1002\/mds.27136","article-title":"Cerebrospinal Fluid Beta-Glucocerebrosidase Activity Is Reduced in Parkinson\u2019s Disease Patients","volume":"32","author":"Parnetti","year":"2017","journal-title":"Mov. Disord."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41531-023-00468-2","article-title":"LRRK2 and GBA1 Variant Carriers Have Higher Urinary Bis(Monacylglycerol) Phosphate Concentrations in PPMI Cohorts","volume":"9","author":"Merchant","year":"2023","journal-title":"npj Park. Dis."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"4845","DOI":"10.1093\/brain\/awad265","article-title":"How Should We Be Using Biomarkers in Trials of Disease Modification in Parkinson\u2019s Disease?","volume":"146","author":"Vijiaratnam","year":"2023","journal-title":"Brain"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00415-026-13683-7","article-title":"Protocol of ASPro-PD: A Phase 3 Trial of Ambroxol to Slow Progression in Genetically Stratified Parkinson\u2019s Disease","volume":"273","author":"Toffoli","year":"2026","journal-title":"J. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/jamaneurol.2025.1687","article-title":"Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical Trial","volume":"82","author":"Silveira","year":"2025","journal-title":"JAMA Neurol."},{"key":"ref_102","unstructured":"(2026, May 26). Phase 1\/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson\u2019s Disease With at Least One GBA1 Mutation (PROPEL) 2026, Available online: https:\/\/clinicaltrials.gov\/study\/NCT04127578."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(23)00205-3","article-title":"Safety and Efficacy of Venglustat in GBA1-Associated Parkinson\u2019s Disease: An International, Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase 2 Trial","volume":"22","author":"Giladi","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"e12813","DOI":"10.7554\/eLife.12813","article-title":"Phosphoproteomics Reveals That Parkinson\u2019s Disease Kinase LRRK2 Regulates a Subset of Rab GTPases","volume":"5","author":"Steger","year":"2016","journal-title":"eLife"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.molmed.2024.07.003","article-title":"LRRK2 in Parkinson\u2019s Disease: Upstream Regulation and Therapeutic Targeting","volume":"30","author":"Xiong","year":"2024","journal-title":"Trends Mol. Med."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2205492119","DOI":"10.1073\/pnas.2205492119","article-title":"Lysosomal Positioning Regulates Rab10 Phosphorylation at LRRK2+ Lysosomes","volume":"119","author":"Kluss","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1038\/s41591-026-04262-4","article-title":"LRRK2-Targeting Antisense Oligonucleotide in Parkinson\u2019s Disease: A Phase 1 Randomized Controlled Trial","volume":"32","author":"Mabrouk","year":"2026","journal-title":"Nat. Med."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"7295","DOI":"10.1038\/s41467-023-42876-1","article-title":"Knockout or Inhibition of USP30 Protects Dopaminergic Neurons in a Parkinson\u2019s Disease Mouse Model","volume":"14","author":"Fang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41573-024-01105-0","article-title":"Targeting Mitophagy in Neurodegenerative Diseases","volume":"24","author":"Antico","year":"2025","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_110","unstructured":"AbbVie (2026, August 10). A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABBV-1088 Oral Dose in Healthy Adult Participants, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06414798."},{"key":"ref_111","unstructured":"AbbVie (2026, August 10). A Study to Assess Multiple Ascending Dose, Drug-Drug Interaction, and Asian Pharmacokinetic Study of ABBV-1088, Available online: https:\/\/clinicaltrials.gov\/study\/NCT06579300."},{"key":"ref_112","unstructured":"Mission Therapeutics (2026, August 10). A Phase I Study in Healthy Volunteers and Parkinson\u2019s Disease (PD) Patients, Available online: https:\/\/clinicaltrials.gov\/study\/NCT07630545."},{"key":"ref_113","unstructured":"Biogen Inc., and Denali Therapeutics Inc (2026, August 10). Biogen and Denali Therapeutics Provide Update on Phase 2b LUMA Study of BIIB122 (DNL151) in Early-Stage Parkinson\u2019s Disease. Available online: https:\/\/investors.biogen.com\/news-releases\/news-release-details\/biogen-and-denali-therapeutics-provide-update-phase-2b-luma."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1002\/mds.26431","article-title":"MDS Research Criteria for Prodromal Parkinson\u2019s Disease","volume":"30","author":"Berg","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-025-00914-0","article-title":"Diagnostic Biomarkers for \u03b1-Synucleinopathies- State of the Art and Future Developments: A Systematic Review","volume":"21","author":"Donadio","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"102603","DOI":"10.1016\/j.pneurobio.2024.102603","article-title":"The STRAT-PARK Cohort: A Personalized Initiative to Stratify Parkinson\u2019s Disease","volume":"236","author":"Stige","year":"2024","journal-title":"Prog. Neurobiol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8086\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T04:15:50Z","timestamp":1789272950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/18\/8086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":116,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["ijms27188086"],"URL":"https:\/\/doi.org\/10.3390\/ijms27188086","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]}}}